- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/24 - Interleukins
Patent holdings for IPC class C12N 15/24
Total number of patents in this class: 278
10-year publication summary
|
16
|
8
|
13
|
18
|
16
|
26
|
21
|
27
|
17
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4329 |
7 |
| Regeneron Pharmaceuticals, Inc. | 4261 |
6 |
| ZymoGenetics, LLC | 14 |
6 |
| Altor BioScience, LLC | 74 |
6 |
| Joint Stock Company "BIOCAD" | 184 |
5 |
| Noile-immune Biotech Inc. | 34 |
5 |
| Board of Regents, The University of Texas System | 5798 |
4 |
| National University Corporation Tottori University | 204 |
4 |
| National University of Singapore | 2453 |
4 |
| Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences | 2034 |
4 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2856 |
4 |
| University Health Network | 1045 |
4 |
| Yale University | 2389 |
4 |
| Nanjing Bioheng Biotech Co., Ltd | 44 |
4 |
| Novartis AG | 10829 |
3 |
| Boehringer Ingelheim International GmbH | 4644 |
3 |
| Merck Patent GmbH | 5818 |
3 |
| Children's Healthcare of Atlanta, Inc. | 245 |
3 |
| Emory University | 1631 |
3 |
| Ottawa Hospital Research Institute | 109 |
3 |
| Other owners | 193 |